Human Reemerging Arboviral Diseases of the Late 21st Century: From Ecological-Epidemiology to Control Strategies

Nasir, Idris Abdullahi; Dangana, Amos; Ahmad, Abdurrahman Elfulaty; Ojeamiren, Iduda; Emeribe, Anthony Uchenna

doi:10.1016/b978-0-12-819400-3.00002-8

Cited by 1 publication

(2 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Yellow fever is a vaccine-preventable acute viral disease transmitted by infected mosquitoes and has the potential to rapidly spread and cause negative public health impact (Cupertino et al, 2019;Nasir et al, 2020;World Health Organization [WHO], 2019a. The causative organism of yellow fever is the Flaviviridae virus, and this is the first arbovirus to be linked with human disease.…”

Section: Introductionmentioning

confidence: 99%

“…The yellow fever virus (YFV) is common in tropical and subtropical regions of Africa and Central/South America, and the disease endemic in 34 African countries (Nigeria among) and 13 Central and South American countries (Cupertino et al, 2019;Kotar & Gessler, 2017;Nasir et al, 2020;WHO, 2016WHO, , 2017WHO, , 2019aWHO, , 2019d. However, outbreaks and resurgence of yellow fever were due to some issues, including inadequate vaccination campaigns, extended periods of increased rainfall and temperatures, environmental perturbations arising from human activity (e.g.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Delay in health‐seeking behaviour: Implication to yellow fever outcome in the 2019 outbreak in Nigeria

Umoke

Eyo³

et al. 2021

Health Soc Care Community

View full text Add to dashboard Cite

Yellow fever is a vaccine-preventable acute viral disease that can rapidly spread and cause serious public health impact. Delay in seeking health care from health facilities is a potential risk of prolonged disease spread. Therefore, this study assessed the delay in health-seeking behaviour and implications for yellow fever outcomes in the 2019 outbreak in Nigeria. Furthermore, the study examined the factors associated with delayed yellow fever vaccine uptake. A retrospective study was conducted from January to December 2019 using 137 cases recorded in the WHO database. The data were analysed using descriptive (frequency and percentages) and the Chi-square test.The results were significant at p < 0.05. Results showed a low uptake of yellow fever vaccine (24.1%) among patients and a median total health-seeking delay of 7 [IQR 7, 9] days. The delay was more among the older age ≥40 years (12 [IQR 12, 29]), females (8 [IQR 8, 11], and rural inhabitants 7 [IQR7, 9], particularly in Izzi LGA (9 [IQR 9, 16] than the other subgroups. Patients' location or place of residence was significantly associated with the yellow fever vaccine uptake (p < 0.000*), and delay (p = 0.003*).Conclusively, the low vaccine uptake was due to the delay in health-seeking behaviour. Thus, the healthcare system in Nigeria needs to intensify mass participation in immunisation programmes. Interventions that promote behavioural change towards immunisation are required. Also, health promotion campaigns to educate rural people on desirable health-seeking behaviour are needed.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%